Cite

HARVARD Citation

    Poon, C. et al. (n.d.). Development of crizotinib, a rationally designed tyrosine kinase inhibitor for non‐small cell lung cancer. International journal of cancer. 140 (9), pp. 1945-1954. [Online]. 
  
Back to record